BioUtah will honor outstanding leaders and companies in Utah’s life sciences community with five awards recognizing contributions to the industry. SALT LAKE CITY, November 5, 2026 — BioUtah today announced its 2026 Life Sciences Awards. Five awards will be presented during the 2026 Utah Life Sciences Summit Nov. 11 at the Hilton Salt Lake City […]
TAVR delivered more than 30% reduction in the composite endpoint of death or heart failure event as compared with clinical surveillance; results published in NEJM.
First FDA-approved biologic specifically designed to cross blood-brain barrier wins award dedicated to exceptional scientific leadership and transformational impact on patient care.
Members of BioUtah participated this past week in a Governor’s Trade Mission to Ireland.
Follow-Up Biopsies Identified High-Grade Lesions or Cervical Cancer in 12 of 20 HPV-Positive Women, Including a Cohort with Predominantly Negative Cytology Results
Solo Pace, Inc. specializes in temporary pacing solutions and systems designed for transcatheter heart valve procedures, including transcatheter aortic valve replacement procedures.
Altitude Lab provides NanoKar with specialized laboratory resources and direct connectivity to global biopharma executives, strategic acquirers, and investors.
Two Student-Led Startups Earn $50k in Funding in Global Medical Innovation Competition
Study Demonstrated 97.3% Sensitivity and 96.0% Specificity Consistent Performance Across Three Test Batches
Company also presents new data at ASRM 2026 showing sperm epigenetics predicts IUI success across clinics and physicians, and that sperm-derived cell-free DNA predicts sperm retrieval outcomes in men with azoospermia
Department of Health – Abu Dhabi, Cleveland Clinic Abu Dhabi partner with Paterna Biosciences to advance male fertility research
Two2Ten Foundation supports the continued development of Seek Labs’ Sequence Ablation Therapeutics (SAT) platform into oncology, honoring the memory of Travis Snyder
Two-year authorization lets military medical teams network SMART-C®. VA approved, and SMART-C Secure™ brings the same security to civilian hospitals.
Funding supports development and multi-center clinical validation of SondeFlux™, a wearable ultrasound device designed to give physicians objective evidence of upper-esophageal reflux NORTH SALT LAKE, Utah, October 19, 2026 — RefloDx, Inc., a Utah medical device company specializing in noninvasive at-home testing, today announced the completion of its $2 million seed round financing. The financing […]
Data from ongoing study supports the potential clinical utility of whole-genome sequencing-based Precise MRD™ to identify recurrence risk and detect disease earlier following surgery
Sale brings the company’s combined voucher proceeds to $413M, following the approval of two gene therapies within the same number of months.
Participation in NUWATIN 2026 to Support Advancement of Strategic Manufacturing, Technology Transfer, and Industrial Localization Initiatives Under Saudi Vision 2030
Financing Strengthens Balance Sheet and Supports Continued Product Innovation and Commercial Growth
Transaction to benefit patients through expanded access and support Myriad’s strategic priorities
WHO Grants Emergency Use Listing for BIOFIRE® Global Fever Special Pathogens Panel, Expanding Access to Differential Diagnostics for the Ebola Response
Additional presentations highlight the design of an ongoing Phase 3 study evaluating tenapanor in chronic idiopathic constipation and the impact of IBS-C symptom burden on quality of life
Ute Indian Tribe Mosquito Abatement Department to bring PCR-based mosquito surveillance testing in house
Ebola Assay in Development for Decentralized Testing on the Co-Dx PCR Platform
New Executive Order prioritizes improved detection and calls for federal R&D programs for rapid diagnostics for mosquito- and tick-borne diseases
BlueWind Medical Announces Humana Coverage of Revi® for Urgency Urinary Incontinence, Expanding Access to Millions of Patients
Myriad Genetics and SOPHiA GENETICS Announce New Collaboration to Advance Prostate Genomic Instability Score Technology
Agreement supports significant investments in U.S. manufacturing, strengthens healthcare resilience and increases domestic production of essential medical consumables used in approximately 90% of U.S. hospital visits
DiscGenics Announces Leadership Transition as IDCT Advances Through Pivotal Phase III Development
Cell-of-origin insights could deepen understanding of CNS injury and disease progression in multiple sclerosis and related diseases
Medical Product Outsourcing hosts the MPO Summit each year at destinations rich in medical device manufacturing. They held their annual Summit on October 7-8 at the Grand America Hotel in Salt Lake City. In doing so, they recognized the significant national role Utah plays in the manufacturing of medical devices. Kelvyn Cullimore, CEO of BioUtah, […]
$1M federal award supports groundbreaking research on rare childhood neurological disorder while expanding student research opportunities.
Integration brings AI-powered vocal analysis into VillageFor’s maternal mental health platform as demand grows for more continuous support throughout the motherhood journey.
